Show simple item record

dc.contributor.authorReyad, Ayman Antoun
dc.date.accessioned2017-09-21T15:01:51Z
dc.date.available2017-09-21T15:01:51Z
dc.date.issued2018-01
dc.identifier.issn1367-7543
dc.identifier.urihttp://hdl.handle.net/2436/620682
dc.description.abstractIn this review, we will discuss the evidence and provide an update on the pharmacological treatments of Behavioural and Psychological symptoms of Dementia (BPSD) especially anti-psychotic medications. Non-pharmacological management of BPSD remains the initial treatment for BPSD; however, pharmacological management have a role in specific situations. This review should support the management of elderly inpatients suffering from Dementia and challenging behaviour in mental health units, general hospitals, community settings and care homes. It will help in raising awareness to the risk of complications such as stroke/death associated with first and second generation antipsychotic medications. It will also highlight some issues in relation to the current guidelines and licensing in the USA, UK and Europe. Good clinical practice used in the management of BPSD to reduce the risk of stroke and other complications is included.
dc.language.isoen
dc.publisherWiley
dc.relation.urlhttp://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1931-227X
dc.subjectBPSD
dc.subjectantipsychotics
dc.subjectPharmacological management
dc.titlePharmacological alternatives to Antipsychotics in the Management of BPSD
dc.typeArticle
dc.identifier.journalProgress in Neurology and Psychiatry
dc.date.accepted2017-07
rioxxterms.funderInternal
rioxxterms.identifier.projectUoW210917AAR
rioxxterms.versionAM
rioxxterms.licenseref.urihttps://creativecommons.org/CC BY-NC-ND 4.0
rioxxterms.licenseref.startdate2019-01-01
refterms.dateFCD2018-10-19T09:05:57Z
refterms.versionFCDAM
html.description.abstractIn this review, we will discuss the evidence and provide an update on the pharmacological treatments of Behavioural and Psychological symptoms of Dementia (BPSD) especially anti-psychotic medications. Non-pharmacological management of BPSD remains the initial treatment for BPSD; however, pharmacological management have a role in specific situations. This review should support the management of elderly inpatients suffering from Dementia and challenging behaviour in mental health units, general hospitals, community settings and care homes. It will help in raising awareness to the risk of complications such as stroke/death associated with first and second generation antipsychotic medications. It will also highlight some issues in relation to the current guidelines and licensing in the USA, UK and Europe. Good clinical practice used in the management of BPSD to reduce the risk of stroke and other complications is included.


Files in this item

Thumbnail
Name:
BPSD paper.docx
Size:
54.27Kb
Format:
Microsoft Word 2007

This item appears in the following Collection(s)

Show simple item record